Sunday 18 October 2026
Export ICCM’s income statement to Excel — free account
IceCure Medical Ltd.
ICCM Healthcare Medical Devices
IceCure Medical Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $3.4 million, up 2.67% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 2,068.2%, free cash flow grew 3.88% and total debt fell 64.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
1.06
0.02
+1.92%
Follow ICCM
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 6 | 1 | 2 | 2 | 4 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 198.99 | 697.06 | 311.69 | 455.31 | 19.09 | 12.98 |
Altman Z-Score |
237.24 | — | 254.99 | (6.97) | (2.51) | 7.38 | 2.94 | (2.97) | (9.18) | (10.01) |
Altman Z″-Score (non-manufacturers) |
(36.15) | — | (25.39) | (20.64) | (13.12) | 2.74 | (1.10) | (17.14) | (31.69) | (29.93) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | (2.37) | (0.17) | 1.43 | (4.13) | (2.57) | (2.79) | (2.21) |
P/Operating CF |
0.00 | 0.00 | 0.00 | (310.05) | (301.05) | (485.71) | (210.79) | (160.75) | (6.14) | (3.68) |
P/B ratio |
0.00 | 0.00 | 0.00 | 187.39 | 196.69 | 106.19 | 61.97 | 130.53 | 7.44 | 3.88 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 187.39 | 196.69 | 106.19 | 61.97 | 130.53 | 7.44 | 3.88 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 198.41 | 691.02 | 307.06 | 452.28 | 16.38 | 9.75 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | (131.14) | (225.15) | (57.61) | (66.20) | (1.88) | (1.06) |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.00 | (131.14) | (216.01) | (54.65) | (62.25) | (1.84) | (1.06) |
Quick Ratio |
5.17 | 0.97 | 3.81 | 1.63 | 0.97 | 6.49 | 5.54 | 2.88 | 1.41 | 1.91 |
Current Ratio |
5.79 | 1.18 | 4.42 | 1.93 | 2.58 | 7.54 | 6.49 | 3.66 | 1.95 | 2.61 |
Net Debt/EBITDA |
0.92 | 0.20 | 1.28 | 1.20 | 0.83 | 2.60 | 1.43 | 0.70 | 0.48 | 0.60 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.44% | 1.15% | 2.12% | 1.42% | 2.29% | 1.28% | 0.09% |
Debt/Equity |
0.00 | (3.64) | 0.00 | 0.03 | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | 0.00 |
Asset Turnover |
0.24 | 0.42 | 0.25 | 0.26 | 0.44 | 0.19 | 0.10 | 0.14 | 0.23 | 0.26 |
Operating CF/Net income |
0.96 | 0.91 | 0.87 | 0.44 | 0.99 | 1.27 | 0.84 | 0.86 | 0.82 | 0.97 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (3.22) | (3.54) | (4.20) | (3.59) | (1.49) | (0.21) | (0.12) |
Interest Coverage |
(682.17) | (81.60) | (93.69) | — | — | — | — | — | — | — |
| (354.30%) | (311.54%) | (227.23%) | (136.41%) | (83.45%) | (60.69%) | (64.83%) | (77.97%) | (160.70%) | (188.78%) | |
| (124.73%) | (173.60%) | (82.59%) | (72.51%) | (42.59%) | (46.54%) | (54.36%) | (62.89%) | (105.69%) | (113.79%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (114.34%) | (300.57%) | (551.50%) | (659.11%) | 0.00% | (5,648.95%) |
Return on Tangible Assets |
(119.75%) | (863.13%) | (87.05%) | (131.57%) | (60.34%) | (36.63%) | (67.51%) | (123.90%) | (235.95%) | (171.61%) |
Average Days of Receivables |
38.38 | 33.06 | 85.26 | 3.81 | 8.87 | 40.22 | 9.23 | 11.64 | 24.51 | 35.75 |
Research and Development Expense of Revenue |
264.34% | 215.73% | 191.53% | 184.45% | 98.47% | 142.03% | 295.72% | 256.21% | 215.62% | 219.98% |
Selling, General and Administrative Expense of Revenue |
264.88% | 194.24% | 155.41% | 141.79% | 71.79% | 146.01% | 293.71% | 266.43% | 305.41% | 263.01% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 22.86% | 5.92% | 7.64% | 60.45% | 40.57% | 26.41% | 40.63% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.10 | 0.22 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1.99%) | (1.99%) | (1.99%) | (1.99%) | (1.04%) | (5.29%) | (9.79%) | (7.99%) | (15.07%) | (23.90%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | (0.76%) | (0.46%) | (1.80%) | (1.60%) | (46.66%) | (70.71%) |
Revenue per Share |
0.12 | 0.11 | 0.09 | 3.59 | 6.78 | 4.35 | 2.50 | 2.12 | 1.94 | 1.60 |
Operating CF per Share |
(0.59) | (0.41) | (0.26) | (4.38) | (6.47) | (13.26) | (11.59) | (8.26) | (7.42) | (6.88) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.23) | (0.39) | (0.56) | (0.72) | (0.32) | (0.04) | (0.02) |
Free Cash Flow per Share |
(0.59) | (0.41) | (0.26) | (4.61) | (6.86) | (13.82) | (12.32) | (8.57) | (7.46) | (6.90) |
Cash per Share |
0.53 | 0.23 | 0.36 | 12.76 | 6.14 | 26.95 | 19.43 | 7.28 | 4.46 | 4.20 |
Shareholders Equity per Share |
0.40 | (0.04) | 0.29 | 7.26 | 9.90 | 28.36 | 20.62 | 8.00 | 4.07 | 4.28 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.40 | (0.04) | 0.29 | 7.26 | 9.90 | 28.36 | 20.62 | 8.00 | 4.07 | 4.28 |
Free Cash Flow |
(3.14) | (2.63) | (3.08) | (2.09) | (3.91) | (13.14) | (15.18) | (13.03) | (12.63) | (14.61) |
Working Capital |
2.67 | 0.29 | 4.00 | 3.31 | 5.88 | 26.30 | 23.79 | 10.31 | 5.24 | 7.78 |
Capital Expenditures |
(0.02) | (0.01) | (0.06) | (0.10) | (0.22) | (0.53) | (0.89) | (0.48) | (0.07) | (0.04) |
Net Current Asset Value |
2.67 | 0.29 | 4.00 | 2.88 | 5.00 | 25.00 | 23.36 | 9.94 | 5.08 | 7.77 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.06 | 0.06 | 0.13 | 0.29 | 0.15 | 0.02 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.87 | 0.76 | 0.42 | 0.22 | 0.21 | 0.18 | 0.18 | 0.21 | 0.27 | 0.30 |
Cash ROIC |
(63.65%) | (122.85%) | (40.53%) | (22.78%) | (42.22%) | (24.67%) | (30.48%) | (55.21%) | (86.38%) | (81.34%) |
Accounts Receivable Turnover |
9.76 | 10.75 | 6.86 | 12.12 | 69.69 | 15.05 | 11.55 | 35.68 | 20.31 | 12.24 |
Accounts Payable Turnover |
3.02 | 3.81 | 2.15 | 2.50 | 2.65 | 2.55 | 2.06 | 3.17 | 2.12 | 2.06 |
Inventory Turnover |
1.35 | 1.70 | 1.36 | 1.65 | 1.63 | 1.29 | 0.68 | 0.75 | 0.86 | 0.93 |
Average Days of Payables |
108.75 | 105.42 | 254.68 | 141.63 | 165.33 | 165.50 | 158.91 | 94.99 | 244.39 | 146.31 |
Days of Inventory on Hand |
278.45 | 207.66 | 367.24 | 224.36 | 272.72 | 367.25 | 635.86 | 430.47 | 394.36 | 445.02 |
Average Receivables |
0.06 | 0.06 | 0.16 | 0.13 | 0.06 | 0.28 | 0.27 | 0.09 | 0.16 | 0.28 |
Average Payables |
0.14 | 0.14 | 0.30 | 0.44 | 0.54 | 0.76 | 0.80 | 0.61 | 0.87 | 1.05 |
Average Inventory |
0.31 | 0.31 | 0.48 | 0.67 | 0.87 | 1.51 | 2.41 | 2.57 | 2.13 | 2.31 |
Average Assets |
2.63 | 1.66 | 4.30 | 6.28 | 8.76 | 21.26 | 31.23 | 23.30 | 14.49 | 13.23 |
Average Common Equity |
0.92 | 0.92 | 1.56 | 3.34 | 4.47 | 16.30 | 26.19 | 18.79 | 9.53 | 7.98 |
Columns are period end dates